Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoblastoma response to chemotherapy.

B Camitta1, R Wells, A Segura

  • 1Department of Pediatrics, Midwest Children's Cancer Center, Milwaukee, WI 53226.

Cancer
|September 1, 1991
PubMed
Summary

A rare C2 osteoblastoma in a child rapidly recurred after surgery. High-dose chemotherapy with methotrexate, doxorubicin, and cisplatin effectively shrank the aggressive tumor, leading to long-term stability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy.

Oral oncology reports·2026
Same author

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.

Nature communications·2023
Same author

A reply to "Relevant factors in the eutrophication of the Uruguay River and the Río Negro".

The Science of the total environment·2021
Same author

Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study.

HIV medicine·2021
Same author

Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group.

Revista clinica espanola·2021
Same author

Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.

HIV medicine·2020

Area of Science:

  • Orthopedic Oncology
  • Pediatric Oncology
  • Neurosurgery

Background:

  • Osteoblastoma is a rare, benign bone tumor, typically treated with surgical excision.
  • Aggressive or recurrent osteoblastomas pose significant treatment challenges, especially in pediatric patients.
  • The C2 vertebral body is a critical and surgically complex location for spinal tumors.

Observation:

  • An 8-year-old boy presented with a rapidly and massively recurrent osteoblastoma of the C2 vertebral body following initial surgical attempts.
  • The recurrent tumor demonstrated aggressive behavior, necessitating alternative treatment strategies.
  • The patient received high-dose combination chemotherapy, including methotrexate, doxorubicin, and cisplatin.

Findings:

  • The osteoblastoma showed progressive shrinkage in response to the neoadjuvant chemotherapy regimen.

Related Experiment Videos

  • Following completion of chemotherapy, the patient achieved disease stability and remained tumor-free for 33 months.
  • This case highlights the potential efficacy of chemotherapy in managing aggressive, recurrent osteoblastomas.

    • Implications:

    • While surgical excision is the primary treatment for osteoblastoma, chemotherapy can be a valuable option for recurrent or aggressive tumors.
    • Neoadjuvant chemotherapy may be considered for surgically challenging or inaccessible osteoblastomas, potentially improving surgical outcomes.
    • This case supports the role of multimodal therapy in managing complex pediatric bone tumors, offering hope for long-term disease control.